(Q39827520)

15 September 2017

Therapeutic implications of inhibition versus killing of Mycobacterium avium complex by antimicrobial agents (English)

1 reference

Mycobacterium avium avium

15 September 2017

1 reference

Yajko DM

1

1 reference

15 September 2017

Nassos PS

series ordinal

2

1 reference

15 September 2017

Hadley WK

series ordinal

3

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 January 1987

1 reference

Antimicrobial Agents and Chemotherapy

15 September 2017

1 reference

15 September 2017

31

1 reference

15 September 2017

1

1 reference

15 September 2017

117-120

1 reference

Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methods

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174666

Comparative in vitro activities of MDL 473, rifampin, and ansamycin against Mycobacterium intracellulare

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174666

Opportunistic pathogens in the genus Mycobacterium

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174666

Ciprofloxacin concentrations in bone and muscle after oral dosing

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174666

Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174666

Pharmacokinetics of three oral formulations of ciprofloxacin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174666

Lamprene (clofazimine) in leprosy. Basic information

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174666

In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174666

In Vitro and In Vivo Susceptibility of Atypical Mycobacteria to Various Drugs

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174666

Treatment of infections in patients with the acquired immunodeficiency syndrome.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174666

Pulmonary manifestations of the acquired immunodeficiency syndrome (AIDS)

17 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3032086

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Dynamic aspects of the in vitro chemotherapeutic activity of ansamycin (rifabutine) on mycobacterium intracellulare

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3032086

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.31.1.117

1 reference

15 September 2017

1 reference

15 September 2017

1 reference